Global and China Veterinary Biologics Market Insights, Forecast to 2027

Publisher Name :
Date: 24-Dec-2021
No. of pages: 160
Inquire Before Buying

Veterinary Biologics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Veterinary Biologics market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Vaccines

- Monoclonal Antibodies

Segment by Application

- Llivestock

- Equine

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Merck

- Zoetis

- Boehringer Ingelheim

- Ceva

- CAHIC

- HVRI

- Ringpu Biology

- Yebio

- DHN

- WINSUN

- Elanco/Eli Lilly

- Virbac

- Jinyu Bio-Technology

- ChengDu Tecbond

- CAVAC

- Kyoto Biken

- FATRO

- Vaksindo

- Bio-Labs

- Avimex Animal

Global and China Veterinary Biologics Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Veterinary Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Biologics Market Size Growth Rate by Type
1.2.2 Vaccines
1.2.3 Monoclonal Antibodies
1.3 Market by Application
1.3.1 Global Veterinary Biologics Market Size Growth Rate by Application
1.3.2 Llivestock
1.3.3 Equine
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Veterinary Biologics Market Size, Estimates and Forecasts
2.1.1 Global Veterinary Biologics Revenue 2016-2027
2.1.2 Global Veterinary Biologics Sales 2016-2027
2.2 Global Veterinary Biologics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Veterinary Biologics Historical Market Size by Region (2016-2021)
2.3.1 Global Veterinary Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Veterinary Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Veterinary Biologics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Veterinary Biologics Sales Forecast by Region (2022-2027)
2.4.2 Global Veterinary Biologics Revenue Forecast by Region (2022-2027)
3 Global Veterinary Biologics Competitor Landscape by Players
3.1 Global Top Veterinary Biologics Manufacturers by Sales
3.1.1 Global Veterinary Biologics Sales by Manufacturer (2016-2021)
3.1.2 Global Veterinary Biologics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Veterinary Biologics Manufacturers by Revenue
3.2.1 Key Veterinary Biologics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Veterinary Biologics Revenue by Manufacturers (2016-2021)
3.2.3 Global Veterinary Biologics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Veterinary Biologics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Veterinary Biologics Revenue in 2020
3.2.6 Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Veterinary Biologics Price by Manufacturers
3.4 Global Veterinary Biologics Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Veterinary Biologics Market Size by Type (2016-2021)
4.1.1 Global Veterinary Biologics Sales by Type (2016-2021)
4.1.2 Global Veterinary Biologics Revenue by Type (2016-2021)
4.1.3 Veterinary Biologics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Veterinary Biologics Market Size Forecast by Type (2022-2027)
4.2.1 Global Veterinary Biologics Sales Forecast by Type (2022-2027)
4.2.2 Global Veterinary Biologics Revenue Forecast by Type (2022-2027)
4.2.3 Veterinary Biologics Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Veterinary Biologics Market Size by Application (2016-2021)
5.1.1 Global Veterinary Biologics Sales by Application (2016-2021)
5.1.2 Global Veterinary Biologics Revenue by Application (2016-2021)
5.1.3 Veterinary Biologics Price by Application (2016-2021)
5.2 Veterinary Biologics Market Size Forecast by Application (2022-2027)
5.2.1 Global Veterinary Biologics Sales Forecast by Application (2022-2027)
5.2.2 Global Veterinary Biologics Revenue Forecast by Application (2022-2027)
5.2.3 Global Veterinary Biologics Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Veterinary Biologics Market Size YoY Growth 2016-2027
6.1.1 China Veterinary Biologics Sales YoY Growth 2016-2027
6.1.2 China Veterinary Biologics Revenue YoY Growth 2016-2027
6.1.3 China Veterinary Biologics Market Share in Global Market 2016-2027
6.2 China Veterinary Biologics Market Size by Players (International and Local Players)
6.2.1 China Top Veterinary Biologics Players by Sales (2016-2021)
6.2.2 China Top Veterinary Biologics Players by Revenue (2016-2021)
6.3 China Veterinary Biologics Historic Market Review by Type (2016-2021)
6.3.1 China Veterinary Biologics Sales Market Share by Type (2016-2021)
6.3.2 China Veterinary Biologics Revenue Market Share by Type (2016-2021)
6.3.3 China Veterinary Biologics Price by Type (2016-2021)
6.4 China Veterinary Biologics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Veterinary Biologics Sales Forecast by Type (2022-2027)
6.4.2 China Veterinary Biologics Revenue Forecast by Type (2022-2027)
6.4.3 China Veterinary Biologics Price Forecast by Type (2022-2027)
6.5 China Veterinary Biologics Historic Market Review by Application (2016-2021)
6.5.1 China Veterinary Biologics Sales Market Share by Application (2016-2021)
6.5.2 China Veterinary Biologics Revenue Market Share by Application (2016-2021)
6.5.3 China Veterinary Biologics Price by Application (2016-2021)
6.6 China Veterinary Biologics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Veterinary Biologics Sales Forecast by Application (2022-2027)
6.6.2 China Veterinary Biologics Revenue Forecast by Application (2022-2027)
6.6.3 China Veterinary Biologics Price Forecast by Application (2022-2027)
7 North America
7.1 North America Veterinary Biologics Market Size YoY Growth 2016-2027
7.2 North America Veterinary Biologics Market Facts & Figures by Country
7.2.1 North America Veterinary Biologics Sales by Country (2016-2021)
7.2.2 North America Veterinary Biologics Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Veterinary Biologics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Veterinary Biologics Market Facts & Figures by Region
8.2.1 Asia Pacific Veterinary Biologics Sales by Region (2016-2021)
8.2.2 Asia Pacific Veterinary Biologics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Veterinary Biologics Market Size YoY Growth 2016-2027
9.2 Europe Veterinary Biologics Market Facts & Figures by Country
9.2.1 Europe Veterinary Biologics Sales by Country (2016-2021)
9.2.2 Europe Veterinary Biologics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Veterinary Biologics Market Size YoY Growth 2016-2027
10.2 Latin America Veterinary Biologics Market Facts & Figures by Country
10.2.1 Latin America Veterinary Biologics Sales by Country (2016-2021)
10.2.2 Latin America Veterinary Biologics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Veterinary Biologics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Veterinary Biologics Market Facts & Figures by Country
11.2.1 Middle East and Africa Veterinary Biologics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Veterinary Biologics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Veterinary Biologics Products Offered
12.1.5 Merck Recent Development
12.2 Zoetis
12.2.1 Zoetis Corporation Information
12.2.2 Zoetis Description and Business Overview
12.2.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Zoetis Veterinary Biologics Products Offered
12.2.5 Zoetis Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Veterinary Biologics Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Ceva
12.4.1 Ceva Corporation Information
12.4.2 Ceva Description and Business Overview
12.4.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ceva Veterinary Biologics Products Offered
12.4.5 Ceva Recent Development
12.5 CAHIC
12.5.1 CAHIC Corporation Information
12.5.2 CAHIC Description and Business Overview
12.5.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CAHIC Veterinary Biologics Products Offered
12.5.5 CAHIC Recent Development
12.6 HVRI
12.6.1 HVRI Corporation Information
12.6.2 HVRI Description and Business Overview
12.6.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 HVRI Veterinary Biologics Products Offered
12.6.5 HVRI Recent Development
12.7 Ringpu Biology
12.7.1 Ringpu Biology Corporation Information
12.7.2 Ringpu Biology Description and Business Overview
12.7.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ringpu Biology Veterinary Biologics Products Offered
12.7.5 Ringpu Biology Recent Development
12.8 Yebio
12.8.1 Yebio Corporation Information
12.8.2 Yebio Description and Business Overview
12.8.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Yebio Veterinary Biologics Products Offered
12.8.5 Yebio Recent Development
12.9 DHN
12.9.1 DHN Corporation Information
12.9.2 DHN Description and Business Overview
12.9.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 DHN Veterinary Biologics Products Offered
12.9.5 DHN Recent Development
12.10 WINSUN
12.10.1 WINSUN Corporation Information
12.10.2 WINSUN Description and Business Overview
12.10.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 WINSUN Veterinary Biologics Products Offered
12.10.5 WINSUN Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Veterinary Biologics Products Offered
12.11.5 Merck Recent Development
12.12 Virbac
12.12.1 Virbac Corporation Information
12.12.2 Virbac Description and Business Overview
12.12.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Virbac Products Offered
12.12.5 Virbac Recent Development
12.13 Jinyu Bio-Technology
12.13.1 Jinyu Bio-Technology Corporation Information
12.13.2 Jinyu Bio-Technology Description and Business Overview
12.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jinyu Bio-Technology Products Offered
12.13.5 Jinyu Bio-Technology Recent Development
12.14 ChengDu Tecbond
12.14.1 ChengDu Tecbond Corporation Information
12.14.2 ChengDu Tecbond Description and Business Overview
12.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.14.4 ChengDu Tecbond Products Offered
12.14.5 ChengDu Tecbond Recent Development
12.15 CAVAC
12.15.1 CAVAC Corporation Information
12.15.2 CAVAC Description and Business Overview
12.15.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.15.4 CAVAC Products Offered
12.15.5 CAVAC Recent Development
12.16 Kyoto Biken
12.16.1 Kyoto Biken Corporation Information
12.16.2 Kyoto Biken Description and Business Overview
12.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Kyoto Biken Products Offered
12.16.5 Kyoto Biken Recent Development
12.17 FATRO
12.17.1 FATRO Corporation Information
12.17.2 FATRO Description and Business Overview
12.17.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.17.4 FATRO Products Offered
12.17.5 FATRO Recent Development
12.18 Vaksindo
12.18.1 Vaksindo Corporation Information
12.18.2 Vaksindo Description and Business Overview
12.18.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Vaksindo Products Offered
12.18.5 Vaksindo Recent Development
12.19 Bio-Labs
12.19.1 Bio-Labs Corporation Information
12.19.2 Bio-Labs Description and Business Overview
12.19.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Bio-Labs Products Offered
12.19.5 Bio-Labs Recent Development
12.20 Avimex Animal
12.20.1 Avimex Animal Corporation Information
12.20.2 Avimex Animal Description and Business Overview
12.20.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Avimex Animal Products Offered
12.20.5 Avimex Animal Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Veterinary Biologics Industry Trends
13.2 Veterinary Biologics Market Drivers
13.3 Veterinary Biologics Market Challenges
13.4 Veterinary Biologics Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Veterinary Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Veterinary Biologics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Vaccines
Table 3. Major Manufacturers of Monoclonal Antibodies
Table 4. Global Veterinary Biologics Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Veterinary Biologics Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Veterinary Biologics Sales by Regions (2016-2021) & (K Units)
Table 7. Global Veterinary Biologics Sales Market Share by Regions (2016-2021)
Table 8. Global Veterinary Biologics Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Veterinary Biologics Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Veterinary Biologics Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Veterinary Biologics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Veterinary Biologics Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Veterinary Biologics Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Veterinary Biologics Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Veterinary Biologics Manufacturers by Revenue (US$ Million) in 2020
Table 16. Veterinary Biologics Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Veterinary Biologics Revenue Share by Manufacturers (2016-2021)
Table 18. Global Veterinary Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Veterinary Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Biologics as of 2020)
Table 20. Key Manufacturers Veterinary Biologics Price (2016-2021) (US$/Unit)
Table 21. Veterinary Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Veterinary Biologics Product Type
Table 23. Date of International Manufacturers Enter into Veterinary Biologics Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Veterinary Biologics Sales by Type (2016-2021) (K Units)
Table 26. Global Veterinary Biologics Sales Share by Type (2016-2021)
Table 27. Global Veterinary Biologics Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Veterinary Biologics Revenue Share by Type (2016-2021)
Table 29. Veterinary Biologics Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Veterinary Biologics Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Veterinary Biologics Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Veterinary Biologics Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Veterinary Biologics Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Veterinary Biologics Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Veterinary Biologics Sales by Application (2016-2021) (K Units)
Table 36. Global Veterinary Biologics Sales Share by Application (2016-2021)
Table 37. Global Veterinary Biologics Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Veterinary Biologics Revenue Share by Application (2016-2021)
Table 39. Veterinary Biologics Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Veterinary Biologics Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Veterinary Biologics Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Veterinary Biologics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Veterinary Biologics Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Veterinary Biologics Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. China Veterinary Biologics Sales (K Units) of Key Companies (2016-2021)
Table 46. China Veterinary Biologics Sales Share by Company (2016-2021)
Table 47. China Veterinary Biologics Revenue (US$ Million) by Company (2016-2021)
Table 48. China Veterinary Biologics Revenue Share by Company (2016-2021)
Table 49. China Veterinary Biologics Sales (K Units) by Type (2016-2021)
Table 50. China Veterinary Biologics Sales Share by Type (2016-2021)
Table 51. China Veterinary Biologics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Veterinary Biologics Price (US$/Unit) by Type (2016-2021)
Table 53. China Veterinary Biologics Sales (K Units) by Type (2022-2027)
Table 54. China Veterinary Biologics Sales Share by Type (2022-2027)
Table 55. China Veterinary Biologics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Veterinary Biologics Revenue Share by Type (2022-2027)
Table 57. China Veterinary Biologics Price (US$/Unit) by Type (2022-2027)
Table 58. China Veterinary Biologics Sales (K Units) by Application (2016-2021)
Table 59. China Veterinary Biologics Sales Share by Application (2016-2021)
Table 60. China Veterinary Biologics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Veterinary Biologics Price (US$/Unit) by Application (2016-2021)
Table 62. China Veterinary Biologics Sales (K Units) by Application (2022-2027)
Table 63. China Veterinary Biologics Sales Share by Application (2022-2027)
Table 64. China Veterinary Biologics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Veterinary Biologics Revenue Share by Application (2022-2027)
Table 66. China Veterinary Biologics Price (US$/Unit) by Application (2022-2027)
Table 67. North America Veterinary Biologics Sales by Country (2016-2021) & (K Units)
Table 68. North America Veterinary Biologics Sales Market Share by Country (2016-2021)
Table 69. North America Veterinary Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Veterinary Biologics Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Veterinary Biologics Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Veterinary Biologics Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Veterinary Biologics Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Veterinary Biologics Revenue Market Share by Region (2016-2021)
Table 75. Europe Veterinary Biologics Sales by Country (2016-2021) & (K Units)
Table 76. Europe Veterinary Biologics Sales Market Share by Country (2016-2021)
Table 77. Europe Veterinary Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Veterinary Biologics Revenue Market Share by Country (2016-2021)
Table 79. Latin America Veterinary Biologics Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Veterinary Biologics Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Veterinary Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Veterinary Biologics Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Veterinary Biologics Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Veterinary Biologics Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Veterinary Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Veterinary Biologics Revenue Market Share by Country (2016-2021)
Table 87. Merck Corporation Information
Table 88. Merck Description and Business Overview
Table 89. Merck Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. Merck Veterinary Biologics Product
Table 91. Merck Recent Development
Table 92. Zoetis Corporation Information
Table 93. Zoetis Description and Business Overview
Table 94. Zoetis Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. Zoetis Product
Table 96. Zoetis Recent Development
Table 97. Boehringer Ingelheim Corporation Information
Table 98. Boehringer Ingelheim Description and Business Overview
Table 99. Boehringer Ingelheim Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. Boehringer Ingelheim Product
Table 101. Boehringer Ingelheim Recent Development
Table 102. Ceva Corporation Information
Table 103. Ceva Description and Business Overview
Table 104. Ceva Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Ceva Product
Table 106. Ceva Recent Development
Table 107. CAHIC Corporation Information
Table 108. CAHIC Description and Business Overview
Table 109. CAHIC Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. CAHIC Product
Table 111. CAHIC Recent Development
Table 112. HVRI Corporation Information
Table 113. HVRI Description and Business Overview
Table 114. HVRI Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. HVRI Product
Table 116. HVRI Recent Development
Table 117. Ringpu Biology Corporation Information
Table 118. Ringpu Biology Description and Business Overview
Table 119. Ringpu Biology Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Ringpu Biology Product
Table 121. Ringpu Biology Recent Development
Table 122. Yebio Corporation Information
Table 123. Yebio Description and Business Overview
Table 124. Yebio Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Yebio Product
Table 126. Yebio Recent Development
Table 127. DHN Corporation Information
Table 128. DHN Description and Business Overview
Table 129. DHN Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. DHN Product
Table 131. DHN Recent Development
Table 132. WINSUN Corporation Information
Table 133. WINSUN Description and Business Overview
Table 134. WINSUN Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. WINSUN Product
Table 136. WINSUN Recent Development
Table 137. Elanco/Eli Lilly Corporation Information
Table 138. Elanco/Eli Lilly Description and Business Overview
Table 139. Elanco/Eli Lilly Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Elanco/Eli Lilly Product
Table 141. Elanco/Eli Lilly Recent Development
Table 142. Virbac Corporation Information
Table 143. Virbac Description and Business Overview
Table 144. Virbac Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Virbac Product
Table 146. Virbac Recent Development
Table 147. Jinyu Bio-Technology Corporation Information
Table 148. Jinyu Bio-Technology Description and Business Overview
Table 149. Jinyu Bio-Technology Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Jinyu Bio-Technology Product
Table 151. Jinyu Bio-Technology Recent Development
Table 152. ChengDu Tecbond Corporation Information
Table 153. ChengDu Tecbond Description and Business Overview
Table 154. ChengDu Tecbond Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. ChengDu Tecbond Product
Table 156. ChengDu Tecbond Recent Development
Table 157. CAVAC Corporation Information
Table 158. CAVAC Description and Business Overview
Table 159. CAVAC Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. CAVAC Product
Table 161. CAVAC Recent Development
Table 162. Kyoto Biken Corporation Information
Table 163. Kyoto Biken Description and Business Overview
Table 164. Kyoto Biken Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 165. Kyoto Biken Product
Table 166. Kyoto Biken Recent Development
Table 167. FATRO Corporation Information
Table 168. FATRO Description and Business Overview
Table 169. FATRO Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 170. FATRO Product
Table 171. FATRO Recent Development
Table 172. Vaksindo Corporation Information
Table 173. Vaksindo Description and Business Overview
Table 174. Vaksindo Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 175. Vaksindo Product
Table 176. Vaksindo Recent Development
Table 177. Bio-Labs Corporation Information
Table 178. Bio-Labs Description and Business Overview
Table 179. Bio-Labs Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 180. Bio-Labs Product
Table 181. Bio-Labs Recent Development
Table 182. Avimex Animal Corporation Information
Table 183. Avimex Animal Description and Business Overview
Table 184. Avimex Animal Veterinary Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 185. Avimex Animal Product
Table 186. Avimex Animal Recent Development
Table 187. Veterinary Biologics Market Trends
Table 188. Veterinary Biologics Market Drivers
Table 189. Veterinary Biologics Market Challenges
Table 190. Veterinary Biologics Market Restraints
Table 191. Veterinary Biologics Customers List
Table 192. Veterinary Biologics Distributors List
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Biologics Product Picture
Figure 2. Global Veterinary Biologics Sales Market Share by Type in 2020 & 2027
Figure 3. Vaccines Product Picture
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Global Veterinary Biologics Sales Market Share by Application in 2020 & 2027
Figure 6. Llivestock
Figure 7. Equine
Figure 8. Other
Figure 9. Veterinary Biologics Report Years Considered
Figure 10. Global Veterinary Biologics Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Veterinary Biologics Market Size 2016-2027 (US$ Million)
Figure 12. Global Veterinary Biologics Sales 2016-2027 (K Units)
Figure 13. Global Veterinary Biologics Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Veterinary Biologics Sales Market Share by Region (2016-2021)
Figure 15. Global Veterinary Biologics Sales Market Share by Region in 2020
Figure 16. Global Veterinary Biologics Revenue Market Share by Region (2016-2021)
Figure 17. Global Veterinary Biologics Revenue Market Share by Region in 2020
Figure 18. Global Veterinary Biologics Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Veterinary Biologics Revenue in 2020
Figure 20. Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Veterinary Biologics Sales Market Share by Type (2016-2021)
Figure 22. Global Veterinary Biologics Sales Market Share by Type in 2020
Figure 23. Global Veterinary Biologics Revenue Market Share by Type (2016-2021)
Figure 24. Global Veterinary Biologics Revenue Market Share by Type in 2020
Figure 25. Global Veterinary Biologics Sales Market Share by Application (2016-2021)
Figure 26. Global Veterinary Biologics Sales Market Share by Application in 2020
Figure 27. Global Veterinary Biologics Revenue Market Share by Application (2016-2021)
Figure 28. Global Veterinary Biologics Revenue Market Share by Application in 2020
Figure 29. China Veterinary Biologics Sales Growth Rate 2016-2027 (K Units)
Figure 30. China Veterinary Biologics Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Veterinary Biologics Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Veterinary Biologics Players Market Share by Revenue in Veterinary Biologics in 2020
Figure 33. China Veterinary Biologics Revenue Share by Type (2016-2021)
Figure 34. China Veterinary Biologics Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Veterinary Biologics Revenue Share by Application (2016-2021)
Figure 36. China Veterinary Biologics Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Veterinary
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs